A deficiency of eNOS-derived NO may exacerbate the early-stage of NASH pathogenesis by changing the fat distribution in a mouse model via the regulation of hepatic tissue blood flow. The gene discussed is NOS3; the disease is metabolic dysfunction-associated steatohepatitis.